COMPARISON OF THE EFFECT OF PRE OPERATIVE NEBULISATION OF DRUGS ON POST OPERATIVE SORE THROAT

COMPARISON OF THE EFFECT OF PRE OPERATIVE NEBULISATION OF DEXMEDETOMIDINE AND CLONIDINE ON POST OPERATIVE SORE THROAT

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/08/035855

Enrollment

Registered

2021-08-23

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: DEXMEDETOMIDINE: ALPHA 2 AGONIST: DRUG. 50 mcg(1ml) with 1mlof normal saline nebulization for 10 minutes and 10 minutes before the procedure Control Intervention1: Clonid

Eligibility

Inclusion criteria

Inclusion criteria: asa physical status 1 and 2

Exclusion criteria

Exclusion criteria: PREVIOUS HISTORY OF SORE THROAT FOR PAST ONE WEEK CHRONIC SMOKER,ASTHMA,CPOD,ORAL INJURIES,HEAD AND NECK INJURIES DIFFICULT AIRWAY (MP 3 OR 4) PREGNANT OR LACTATING WOMEN PATIENT REFUSAL

Design outcomes

Primary

Measure	Time frame
INCIDENCE AND SEVERITY OF SORE THROATTimepoint: INCIDENCE AND SEVERITY OF SORE THROAT after surgery for three consecutive days.(post operative day 1,2,3)	—

Secondary

Measure	Time frame
BLOOD PRESSURE AND HEART RATE ADVERSE EFFECTSTimepoint: ONE YEAR	—

Countries

India

Contacts

Public ContactMithra Rajasegar self

sri manakula vinayaka medical college- pondicherry

drkrishnaprabu@gmail.com9943770977

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026